Medtree reports these substances can slow stomach emptying, which anaesthetists say may raise aspiration risk during procedures.
Recap by typeshit. Post by @medtreeau on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Dissolving peptide films are spreading in biohacking circles. The piece sorts out what's approved, what's being sold and what the science supports.
A preprint using health records found BPC-157 users rose from about 54 in early 2022 to 1,018 in early 2026, and most waited two months to tell a doctor.
Loading…